Add the specialty areas of your choice to tailor to your professional interests.
Save & Create free account
No thanks, just apply selection
I already have an account. Login

User login

We offer our registered users tailored information, free online courses and exclusive content.

Can't find your password?
Reset it here.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Growth Hormone Therapies: safety and adherence

Growth Hormone Therapies: safety and adherence
  • Endocrinology and metabolism
  • Growth disorder
Regional workshop by Excemed
Tuesday, May 30 2017
Rio de Janeiro, Brazil



Event format

Multidisciplinary approach


English with simultaneous translation from/to Portuguese

Registration status

To register for this event, contact

For registration, accommodation and any logistic inquiry please contact:

Meridiano Congress International

Congress Manager: Federica Russetti

T +39 06 88 595 209 - F +39 06 88 595 234

Registration fee


Target audiences

Latin American paediatric endocrinologists
scientists and all healthcare professionals involved in managing children with growth hormone disorders.



Access resources by clicking the Outcomes tab or scroll down to the scientific programme.


This meeting will be live streamed

When: 30 May 2017


Time: 8:45 am local time

Need help? Watch this video to understand how to join the live stream.


Therapy with recombinant human Growth Hormone (rhGH) is widely available and has been the most important treatment for several growth disorders in childhood since 1985. Great efforts have been made, through single centre studies and international multi-centre studies, to collect data on patient compliance and long-term safety.  Both issues are still points of discussion worldwide.

Achieving consensus on compliance and long-term safety is not straightforward when considering the magnitude of data required, the heterogeneity of growth disorders treated with rhGH, as well as the varying rhGH dosages and devices. Parents and caregivers involved in the care of these children still face doubts about optimal follow-up treatment.

This workshop will offer the most updated scientific evidence on long-term safety of rhGH therapy and look at how to assess and improve patient compliance. Milestones and new insight on these issues will be discussed by international experts who will use the opportunity to improve how rhGH therapy is managed in childhood.

Learning objectives

• Assess and improve adherence in patients on rhGH treatment
• Manage patients with growth hormone disorders (GHD) according to most updated data on long-term safety
• Manage patients with Turner Syndrome on rhGH therapy
• Assess effectiveness of rhGH therapy in SGA patients
• Arrange transition of GHD patients from childhood to adulthood

Accreditation details

An application has been made to the EACCME ® for CME accreditation of the EXCEMED workshop “Growth Hormone Therapies: safety and
adherence” to be held on 30 May 2017 in Rio de Janeiro, Brazil.

Additional information

EXCEMED designed this programme with the endorsement of the Brasilian Society of Paediatrics (SBP - Sociedade Brasileira de Pediatria).

Scientific programme

Tuesday, 30 May 2017

08.45 Welcome and introduction
P.F. Collett-Solberg (Brazil)

Session I

09.00 L1:  How to assess and improve adherence in patients on rhGH therapy  VIDEO LECTURE
P.F. Collett-Solberg (Brazil)

09.30 L2: Long-term effect and safety of rhGH in Turner syndrome
P. Chatelain (France)

10.00 L3: Children small for gestational age and rhGH therapy: safety and effect on cardiometabolic risk
A.C.S. Hokken-Koelega (The Netherlands)

10.30   Panel discussion

11.00 Coffee break 

Session II

11.30 L4:  Long-term safety of rhGH therapy in children with GH deficiency
L. Sävendahl (Sweden)

12.00 L5: Transitional period: differences of GH treatment follow-up from childhood to adulthood  VIDEO LECTURE
A.A.L. Jorge (Brazil)

12.30 L6: Personalized approach to rhGH treatment: potential impact on outcome, adherence and safety  VIDEO LECTURE
F. Cassorla (Chile)

13.00   Panel discussion

13.30 Lunch 

Session III

14.30    Three parallel working groups: Problem solving of clinical cases

Case study: Boy, healthy but referred due to slow growth in recent years

Case study: 5 11/12 yrs old males referred for short stature

15.30   Discussion in plenary session of clinical cases previously discussed by the working groups

16.30   Concluding remarks
P.F. Collett-Solberg (Brazil)

16.45 End of the workshop

CME provider

EXCEMED - Excellence in Medical Education



Fernando Cassorla

Institute of Maternal and Child Research
University of Chile
Santiago de Chile, Chile

Lars Sävendahl

Department of Woman and Child Health
Karolinska Institutet
Stockholm, Sweden

Alexander Jorge

Associate Professor of Medicine
Genetic Endocrinology Unit
The Endocrinology Division of University of Sao Paulo School of Medicine
School of Medicine University of Sao Paulo
São Paulo, São Paulo, Brazil

Pierre Chatelain

Professor Emeritus of Pediatrics
Collège of Pediatrics
Université Claude Bernard Lyon 1
Lyon, France
Slide kit
Paulo Ferrez Collett-Solberg
Endocrinology and metabolism
Paulo Ferrez Collett-Solberg
Endocrinology and metabolism
Slide kit
Paulo Ferrez Collett-Solberg
Endocrinology and metabolism
Slide kit
Alexander Jorge
Endocrinology and metabolism